ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000245059.2	Cytarabine	Bladder urothelial carcinoma	0.000851725	Sensitive
ENSG00000245059.2	Cytarabine	Pancreatic adenocarcinoma	0.00166816	Sensitive